1. Home
  2. ATGL vs NGEN Comparison

ATGL vs NGEN Comparison

Compare ATGL & NGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Technology Group Limited

ATGL

Alpha Technology Group Limited

N/A

Current Price

$8.90

Market Cap

154.9M

Sector

N/A

ML Signal

N/A

Logo NervGen Pharma Corp. Common stock

NGEN

NervGen Pharma Corp. Common stock

SELL

Current Price

$1.82

Market Cap

175.3M

Sector

N/A

ML Signal

SELL

Company Overview

Basic Information
Metric
ATGL
NGEN
Founded
2017
2017
Country
Hong Kong
Canada
Employees
N/A
N/A
Industry
Sector
Exchange
Nasdaq
Nasdaq
Market Cap
154.9M
175.3M
IPO Year
2023
2018

Fundamental Metrics

Financial Performance
Metric
ATGL
NGEN
Price
$8.90
$1.82
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
102.1K
★ 542.8K
Earning Date
01-27-2027
11-27-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.97
$1.28
52 Week High
$50.00
$5.97

Technical Indicators

Market Signals
Indicator
ATGL
NGEN
Relative Strength Index (RSI) 53.51 67.36
Support Level $7.24 $1.85
Resistance Level $11.20 $2.32
Average True Range (ATR) 0.83 0.14
MACD -0.21 0.07
Stochastic Oscillator 29.46 71.88

Price Performance

Historical Comparison
ATGL
NGEN

About ATGL Alpha Technology Group Limited

Alpha Technology Group Ltd is a Hong Kong-based AI company. Its business focuses on two main directions: building Exclusive Large Language Model solutions and developing AI Agents. The group specializes in creating Exclusive Large Language Models (LLMs) and bespoke AI platforms. These solutions serve as custom AI brains, enabling enterprises to harness their data for strategic decision-making and operational performance. It guides companies of all sizes through digital transformation with scalable, AI-driven solutions that are ESG-sustainable and designed for long-term growth. The cutting-edge offerings, AlphaClaw AI Agents and the AlphaClaw AI Agent Marketplace to empower organizations across diverse industries to optimize operations, automate workflows, and unlock data-driven insights.

About NGEN NervGen Pharma Corp. Common stock

NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is the discovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.

Share on Social Networks: